Machine learning-based mortality prediction models for Crimean-Congo hemorrhagic fever patients

Bahadır Orkun Ozbay1, Aliye Bastug2, Arzu Ceren Yiğit3

  • 1Ministry of Health, Tokat State Hospital, Department of Infectious Diseases and Clinical Microbiology, Tokat, Turkey.

PubMed

Insights

Machine learning models identified key risk factors for mortality in Crimean-Congo hemorrhagic fever (CCHF). Platelet count, neutrophil-to-lymphocyte ratio (NLR), and neutrophil count are crucial for predicting patient outcomes.

Area of Science:

  • Infectious Diseases
  • Medical Informatics
  • Biostatistics

Background:

  • Crimean-Congo hemorrhagic fever (CCHF) poses a significant public health threat.
  • Identifying mortality risk factors in CCHF patients is crucial for timely intervention.
  • Machine learning offers advanced tools for analyzing complex disease data.

Purpose of the Study:

  • To identify risk factors for mortality in CCHF patients.
  • To evaluate the predictive performance of machine learning models for CCHF mortality.
  • To determine the most effective parameters for predicting CCHF-related deaths.

Main Methods:

  • Utilized machine learning algorithms including XGboost, Logistic Regression, Random Forest, LightGBM, and Gradient Boosting Classifier.
  • Developed predictive models using data from 891 confirmed CCHF cases.
  • Evaluated model performance using Receiver Operating Characteristic (ROC) analysis and Area Under the Curve (AUC).

Main Results:

  • Achieved high predictive performance with AUC values of 0.849 (XGboost), 0.919 (Logistic Regression), and 0.853 (Gradient Boosting Classifier).
  • Identified platelet count, neutrophil-to-lymphocyte ratio (NLR), and neutrophil count as top predictors of mortality.
  • The overall fatality rate among confirmed CCHF cases was 3.3%.

Conclusions:

  • Machine learning models, particularly Logistic Regression, XGboost, and Gradient Boosting Classifier, can effectively predict CCHF mortality.
  • Platelet count, NLR, and neutrophil count are significant indicators for assessing mortality risk in CCHF patients.
  • These findings can aid in clinical decision-making and resource allocation for CCHF management.
Abstract